Decreasing urinary PAH metabolites and 7-methylguanine after smoking cessation.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractOBJECTIVE: Humans are exposed to various carcinogens by smoking. Urinary metabolites of polycyclic aromatic hydrocarbons (PAH), one of the major carcinogens in cigarette smoke, were measured as the environmental carcinogen exposure marker for humans. We evaluated urinary exposure markers for smoking cessation. METHOD: In this study, we measured cigarette smoke exposure markers, such as urinary cotinine, PAH exposure markers, such as urinary 1-hydroxypyrene (1-OHP), 2-naphthol (2-NP) and 1-naphthol (1-NP), as well as a methylating chemical exposure marker, 7-methylguanine (7-MeG). The before smoking cessation levels of these markers, and the after smoking cessation levels were then compared. Eighteen subjects participated in this smoking cessation program. RESULTS: Levels of all of four markers were found to have decreased by 19-54% after smoking cessation. Urinary cotinine, 1-OHP, 2-NP and 7-MeG levels were found to have significantly decreased after smoking cessation. There were positive correlations between cotinine and three urinary PAH markers and between 1-OHP, 2-NP and 7-MeG. CONCLUSION: PAH metabolites were better biomarkers of smoking cessation than 7-MeG. Analyzing urinary metabolites or urinary DNA adducts is suitable for epidemiological studies.
CitationInt Arch Occup Environ Health 2006, 79 (7):545-549
DescriptionBiomarkers of exposure & effect:: validationBiomarker: cigarette Smoke: urinary cotinine, PAH Exposure: urinary 1-hydroxypyrene (1- OHP), 2-naphthol (2-NP) and 1-naphthol (1-NP) methylating chemical exposure: 7- methylguanine (7-MeG).Exposure/effect represented: PAHStudy type (in vitro, animals, humans): humansStudy design (if human): cross-sectionalStudy size (if human): 18 individualsMode of exposure (if in vivo) (acute, chronic, root of exposure): smoking cessationMethod of analysis: HPLCSensitivity (LOD): for 1-OHP 0.001μg/l, for 1 and2-NP 0.04μg/lAccuracy: for 1-OHP CV 8%, for 1 and2-NP CV 7.2%, 2.5% respectively, for 7-MeG CV 4.3%Inter-individual variation: The urinary 1-OHP levels of smokers ranged from 0.032 to 0.407, and the mean ± SD was 0.16±0.11 lg/g Cr.Dose-response: The mean levels of five markers decreased after smoking cessation by 54% (7-MeG) to 19% (1-NP). The levels of cotinine, 1-OHP, 2-NP and 7-MeG significantly decreased after smoking cessation. KEYWORDS CLASSIFICATION: analogs & derivatives;analysis;Adult;biomarkers of exposure & effect: field studies;Guanine;Humans;Hydrocarbons;Japan;Middle Aged;Polycyclic Hydrocarbons,Aromatic;Research;Smoking Cessation;urine.
- Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers.
- Authors: St Helen G, Goniewicz ML, Dempsey D, Wilson M, Jacob P 3rd, Benowitz NL
- Issue date: 2012 Apr 16
- Environmental and biological monitoring of exposures to PAHs and ETS in the general population.
- Authors: Aquilina NJ, Delgado-Saborit JM, Meddings C, Baker S, Harrison RM, Jacob P 3rd, Wilson M, Yu L, Duan M, Benowitz NL
- Issue date: 2010 Oct
- Levels of urinary metabolites of four PAHs and cotinine determined in 1016 volunteers living in Central Italy.
- Authors: Tombolini F, Pigini D, Tranfo G, Paci E, Carosi I, Marini F, Bauleo L, Ancona C, Forastiere F
- Issue date: 2018 Oct
- Involuntary tobacco smoke exposure and urinary levels of polycyclic aromatic hydrocarbons in the United States, 1999 to 2002.
- Authors: Suwan-ampai P, Navas-Acien A, Strickland PT, Agnew J
- Issue date: 2009 Mar
- Air concentrations and urinary metabolites of polycyclic aromatic hydrocarbons among paving and remixing workers.
- Authors: Väänänen V, Hämeilä M, Kontsas H, Peltonen K, Heikkilä P
- Issue date: 2003 Oct